Can metformin reduce the risk of cancer for those with type 2 diabetes?… In previous studies, metformin has been shown to decrease the risk of cancer in type 2 diabetes. A recent meta-analysis showed a 34% reduction in the incidence of any cancer and a 33% reduction in cancer mortality; …
Read More »Many Type 2 Patients Discouraged from Taking Metformin
Amending the label for metformin could open up the drug to a million more patients… Researchers from Penn Medicine and Weill Cornell Medical College report this week in a published research letter that, many patients with type 2 diabetes in the United States may be discouraged from taking metformin — …
Read More »Metformin for Obese Children
Metformin was linked to reduced food intake, decreased hunger ratings, and increased fullness ratings… For obese hyperinsulinemic children, metformin seems to decrease perceived hunger and increase perceived fullness, according to a published study. Mopelola A. Adeyemo, M.P.H., from the National Institutes of Health in Bethesda, Md., and colleagues examined the …
Read More »New Approach Targets Type 2’s Poorly Controlled With Metformin
Add-on of saxagliptin plus dapagliflozin shows greater improvements in glycemic control versus the use of single drug with metformin…. Because of the progressive nature of the disease, patients with type 2 diabetes regularly require various antidiabetic agents to achieve and maintain glycemic control. This study assessed the efficacy and safety …
Read More »Interview with NuSirt CEO Joe Cook, Jr: Improving Metformin Treatment, Part 2
This week, we continue our exclusive short interview series with NuSirt CEO, JC, in which he talks about some of the groundbreaking work his company is doing to increase the effectiveness of metformin. Steve Freed, Publisher, Diabetes in Control: What actually brought you to taking this compound and combining it …
Read More »Interview with NuSirt CEO Joe Cook, Jr: Improving Metformin Treatment, Part 1
This week, we’re taking a break from our regularly featured section on avoiding medication mistakes to bring you this exclusive interview series with NuSirt CEO, JC, in which he talks about some of the groundbreaking work his company is doing to increase the effectiveness of metformin. Steve Freed, Publisher, Diabetes …
Read More »FDA Approves Xigduo XR, a New Dapagliflozin-Metformin Combination
The once-daily oral tablet is the first in the U.S. to combine the SGLT-2 inhibitor dapagliflozin with the biguanide extended-release (XR) metformin hydrochloride.. The US Food and Drug Administration (FDA) has approved a once-daily combination of dapagliflozin and metformin hydrochloride extended-release (Xigduo XR, AstraZeneca) for the treatment of adults with …
Read More »Metformin Is Best Initial Oral Drug for Lowering Glucose Levels in Diabetes Patients
Metformin, sulfonylureas, thiazolidinedione, and DPP-4 inhibitors were compared to evaluate the effects on the time to subsequent treatment… There are many classes of oral drugs used for diabetes therapy, but there is a lack of evidence as to which drug is best for use as initial therapy. Most patients diagnosed …
Read More »FDA Accepts Filing of NDA for Empagliflozin/Metformin Fixed-dose Combination
The single pill could help type 2 diabetes patients manage their blood sugar more effectively…. The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investigational compound being studied for the treatment of adults …
Read More »SGLT2 Inhibitors as Add-On for Poorly Controlled Patients on DPP-4s and Metformin
As the diabetes epidemic continues to grow, practitioners are increasingly searching for medication solutions that can help patients to better manage their diabetes. This month, we have a recent slides series from the ADA showing the positive effects of adding-on SGLT-2 inhibitors to the medication regimen of patients on DPP-4’s …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.